178results about How to "Formulation stability" patented technology

The polymer for cosmetics produced by polymerizing (A) a fluorine-containing (meth)acrylate, and (B) at least one silicon-containing polymerizable compound selected from the group consisting of a mercapto-modified silicone, an azo group-containing silicone and a polymerizable silane can be blended easily in cosmetic preparations and can form a film excellent in a water proofing property, a water- and oil-repellency, feelings in use and safety. This copolymer for cosmetics can improve the drawbacks of fluorine compound-treated powders.

Disclosed is a topical composition comprising: (1) a porous spherical disintegrative silica impregnated with a water-insoluble skin benefit agent, wherein: (a) the porous spherical disintegrative silica has an average volume particle size of from about 3 μm to about 20 μm, a maximum particle size of no more than about 50 μm, and a pore volume of from about 1.5 cm³/g to about 3.0 cm³/g; and provides a certain dynamic viscoelasticity when sheared; (b) the water-insoluble skin benefit agent having a solubility in water at less than about 0.1 g/l at 25° C. and having a molecular weight of no more than about 5,000, selected from the group consisting of liquid water-insoluble skin benefit agents, solid water-insoluble skin benefit agents which dissolve in liquid water-insoluble skin benefit agents, solid water-insoluble skin benefit agents which dissolve in emollients and/or volatile solvents, and mixtures thereof; and (2) a suitable carrier.

A cylindrical steam reforming unit comprising a plurality of cylindrical bodies consisting of a first cylindrical body, a second cylindrical body and a third cylindrical body of successively increasing diameters disposed in a concentric spaced relation, a radiation cylinder disposed within and concentrically with the first cylindrical body, a burner disposed in the radial central portion of the radiation cylinder, and a reforming catalyst layer with a reforming catalyst filled in a gap between the first and second cylindrical bodies, wherein a CO shift catalyst layer and a CO removal catalyst layer are disposed in a gap between the second and third cylindrical bodies, the CO shift catalyst layer being formed in a gap with the direction of flow reversed at one axial end of the reforming catalyst layer and through a heat recovery layer of predetermined length. According to this reforming unit, without internally disposing a heat insulation layer, a cooling mechanism or the like, the reforming catalyst layer, CO shift catalyst layer, and CO removal catalyst layer can be integrated, achieving various useful effects, including size and weight reductions and the shortening of startup time.

The present invention discloses II kinds of andrographolide sulfonated derivatives with the actions of resisting bacteria, relieving inflammation and reducing fever and medicine composition containing them. They can be used for preparing freeze-dried powder, injection or oral preparation, and can be used for curing the diseases of pneumonia, bronchitis, tonsillitis and bacillary dysentery, etc.

A rapidly disintegrating tablet for oral administration of acid-labile active ingredients is described. The rapidly disintegrating tablet for oral administration of an acid-labile active ingredient comprises a plurality of individual active ingredient units together with pharmaceutical excipients, where the acid-labile active ingredient is present in the individual active ingredient units in a matrix composed of a mixture comprising at least one solid paraffin and one or more substances from the group of fatty alcohol, triglyceride and fatty acid ester, and where excipients which, on oral intake of the tablet, bring about rapid disintegration of the tablet are present.

The present invention relates to the field of pharmaceutical technology and describes a novel advantageous preparation for an active ingredient. The novel preparation is suitable for producing a large number of pharmaceutical dosage forms. In the new preparation an active ingredient is present essentially uniformly dispersed in an excipient matrix composed of one or more excipients selected from the group of fatty alcohol, triglyceride, partial glyceride and fatty acid ester.

A lipid-bearing preparation and method for preparing same in particular in the form of a stick or a workable paste, which is suitable for cosmetic uses, in particular in the field of decorative cosmetics for coloring and improving the appearance of the skin, the lips and the eyelids. The lipid-bearing preparation is in water-free form and contains in the lipid phase exclusively vegetable-base raw materials.

The present invention discloses a kind of six spirits ointment for external application, including six spirits adhesive plaster, six spirits rubber plaster, six spirits babu preparation and six spirits ointment. It is made up by using six spirits pill powder as main medicine and adding matrix through a certain preparation process, and has the functions of clearing away heat and toxic material, relieving inflammation and stopping pain and can obtain good therapeutic effect for curing furuncle in children, large carbuncle, acute mastitis, innominate inflammatory swelling, herpes and mammitis, etc.

The invention relates to a bleeding stopping starch and an application thereof. The bleeding stopping starch is prepared through redenaturation of denaturated starch in the prior art, and microwave processing. The bleeding stopping starch has the advantages of excellent water absorption effect, safety and stability, has biocompatibility, and can be directly applied to bleeding wounds.

The invention discloses a snail control insecticide of compound niclosamide ethanolamine salt suspending agent which comprises the constituents (by weight portion) of niclosamide ethanolamine salt 1-50 parts, methaldehyde 0.01-5 parts, dispersing agent 1-20 parts, wetting agent 0.5-20 parts, and thickening agent 0.05-10 parts, and balancing water. The invention also discloses the process for preparing the suspending agent.

The invention provides a high-content toltrazuril soluble powder, as well as a preparation method and application of the high-content toltrazuril soluble powder, relates to the field of the soluble powders, preparation methods and application of the soluble powders, and aims at solving the problems of the existing preparation method that the toltrazuril preparation is low in water solubility, low in bioavailability, poor in stability, and easy to generate precipitate and discolor so that the treatment effects and application of the toltrazuril preparation are greatly limited. The high-content toltrazuril soluble powder is prepared from toltrazuril, an alkaline pH (Potential of Hydrogen) regulator, a cosolvent and a soluble filler in parts by weight. The preparation method comprises the following steps of: 1, weighing; 2, mixing and preparing solution; and 3 preparing the powder by the spray drying process. The application is the application of the high-content toltrazuril soluble powder serving as the raw material in tablet preparations, granular preparations and freeze-dried powder preparations. The preparation method is simple in preparation process; the prepared powder contains the toltrazuril up to 60% and is quick to dissolve; and the preparations can be placed for three years at the room temperature without packing and discoloring. The high-content toltrazuril soluble powder is applicable to the field of veterinary drug preparations.

The invention discloses a probiotics preparation for conditioning infant intestinal tracts. The preparation is prepared by the following steps: taking walnut oil or plant blend oil taking walnut oil as a main component as a carrier, adds probiotics and other blend components into the carrier, performing blending at low temperature, and carries out negative-pressure deoxygenation to enable the probiotics to be embedded in the carrier so as to obtain drops. The method is simple, the process is easy to control, and the drops are stable in performance, do not solidify at low temperature, and are uniform in components. The viable bacteria in the probiotic drops are always in a dormant state, and the drops are stable after long-time preservation, light in taste, and natural and safe. After the drops are taken, the drops can withstand the acid and alkali environment in a human body, the survival rate of probiotics is high, the probiotics are rapidly planted and propagated in the intestinal tract of the human body, and the balance of microecology is adjusted, so that various intestinal tract problems are safely, effectively and efficiently solved. The method is suitable for preparing the probiotic preparation, and the preparation is further used for conditioning symptoms such as constipation and diarrhea in intestinal tracts of infants under the age of 3 years.

Disclosed is a glass composition which can be suitably used as a glass filler to be blended into a polycarbonate resin. This glass composition contains, in mass %, 50≦SiO₂≦60, 8≦Al₂O₃≦15, 0≦MgO≦10, 10≦CaO≦30, 0≦Li₂O+Na₂O+K₂O<2, and 5<TiO₂≦10, and does not substantially contain B₂O₃, F, ZnO, SrO, BaO and ZrO₂.

The invention relates to a preparation for preventing and treating adverse events of atherosclerosis and cardio-cerebrovascular embolism as well as the complications thereof, i.e. a clopidogrel hydrogen sulfate tablet and a preparation method thereof. The tablet comprises clopidogrel hydrogen sulfate, a filler, a disintegrating agent, a lubricating agent, an adhesive, and a film coating premixing agent. The preparation method is characterized by the steps of: weighing the filler, the disintegrating agent in a proportion specified in the prescription, mixing them well, making wet granules with the right amount of the adhesive, drying the wet granules at a temperature of 40-60DEG C, sieving the granules through a sieve of 24 meshes and finishing the granules, adding clopidogrel hydrogen sulfate and the lubricating agent and mixing well, then conducting tabletting, coating and packaging, thus obtaining the tablet. The tablet of the invention has the characteristics of simple prescription and process, good stability, high bioavailability, low cost, high production efficiency and the like.

The invention discloses a Shuanghuanglian effervescence tablet added with a moisture-proof agent or a drying agent and a preparation method of the Shuanghuanglian effervescence tablet, wherein the raw medicine materials of the effervescence tablet comprise Shuanghuanglian extract powder, an effervescence agent, the moisture-proof agent or the drying agent, a flavoring agent and a lubricating agent. The Shuanghuanglian effervescence tablet has the advantages of reasonable proportion of a main medicine and auxiliary materials, good formation and stability, good clarity after disintegration, convenience in use and favorable mouth feel, and the compliance of the Shuanghuanglian effervescence tablet is increased and medicine effect is guaranteed.